NEJM Evidence Issues Research Articles in May 2024 Edition
May 10, 2024
May 10, 2024
WALTHAM, Massachusetts, May 10 -- NEJM Evidence, a peer-reviewed journal from New England Journal of Medicine Group that says it presents clinical trial design and decision-making, published research articles on the following topics in its May 2024 edition (Vol. 3, No. 5):
Original Articles:
* CDK4/6 Inhibitor Efficacy in ESR1-Mutant Metastatic Breast Cancer
* A Trial of Automated Outbreak Detection to Reduce Hospital Pathogen Spread
* Intrana . . .
Original Articles:
* CDK4/6 Inhibitor Efficacy in ESR1-Mutant Metastatic Breast Cancer
* A Trial of Automated Outbreak Detection to Reduce Hospital Pathogen Spread
* Intrana . . .
